Development and Evaluation of Baclofen Orodispersible Tablets by Sublimation Method
Abstract
Purpose: Baclofen (BCF) is a novel muscle relaxant and antispasmodic drug that belongs to the BCS-III drug class, having low solubility and high permeability used for treating multiple sclerosis symptoms such as spasticity, stiffness, and pain. The aim of the present work is an attempt to develop orodispersible tablets of BCF by using camphor, menthol as sublimating agents and crospovidone, sodium starch glycolate as superdisintegrants.
Methods: The tablets were prepared by direct compression technique. The FTIR and DSC were used to investigate the drug excipients compatibility. The prepared tablets were subject to investigating thickness, hardness, weight variation, friability, drug content uniformity, swelling index, disintegration time and In-vitro drug release studies.
Results: The FTIR and DSC studies suggest that there is no interaction between the drug and excipients. All the pre-compressed parameters were shown in acceptable limits. The formulated batch (F6) tablets containing crospovidone (12%) and camphor (30%), showing rapid disintegration <18 sec and In-vitro drug release was achieving the highest release of 98.94%w/w at the end of 15 min, followed by Korsmeyer and Peppa’s model, shows diffusion co-efficient n = 0.7606, which indicates the drug release from tablets by the non-Fickian diffusion mechanism.
Conclusion: The concentration of sublimating agent in the formulation creates highly porous tablets that significantly increase disintegration and promote faster drug release. Investigation of the research work was concluded that the addition of superdisintegrants and sublimating agents in the formulation of orodispersible tablets by direct compression is a novel technique to speed up drug release and improve patient compliance.
Keywords: Baclofen Orodispesiable Tablets, Sublimation Method, Crospovidone, Peppas model, Non- Fickain diffusion.
Keywords:
Baclofen Orodispesiable Tablets, Sublimation Method, Crospovidone, Peppas model, Non- Fickain diffusionDOI
https://doi.org/10.22270/jddt.v15i5.7094References
1. Verduzco-Gutierrez, Monica, Nicholas c Ketchum, Hand book of spasticity A Practical approach management, Springer publishing, DOI.101.1891/9780826139757.
2. Tripathi KD. Essential of Medical Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd. 6th edn 2008;627-38. 17.
3. Schlatter, J. Special Issue "Recent Advances in Oral Drug Delivery Development". Pharmaceuticals 2023, 16, 1289. https://doi.org/10.3390/ ph16091289. https://doi.org/10.3390/ph16091289 PMid:37765097 PMCid:PMC10538212
4. Roshan K, Keerthy HS. Orodispersible Tablets: A Compendious Review. Asian Journal of Pharmaceutical Research and Development. 2021 Jun 15;9(3):66-75. https://doi.org/10.22270/ajprd.v9i3.947
5. Nayak AK, Manna K. Current developments in orally disintegrating tablet technology. Journal of Pharmaceutical Education and Research, Jun. 1, 2011; 2(1): 21.
6. Sharma D. Fast Disintegrating Tablets: A Review on An Emerging Trend in Novel Oral Drug Delivery Technology and New Market Opportunities. Journal of Drug Delivery and Therapeutics. 2012 May 14;2(3). https://doi.org/10.22270/jddt.v2i3.125
7. Jassem NA. Orodispersible tablets: A review on recent trends in drug delivery. Int. J. Drug Deliv. 2022; 12:432-6.
8. Arora P, Sethi VA. Orodispersible tablets: A comprehensive review. Int J Res Dev Pharm Life Sci. 2013 Feb;2(2):270-84.
9. Kakade SM, Mannur VS, Ramani KB, Dhada AA, Naval CV, Bhagwat A. Formulation and evaluation of mouth dissolving tablets of Losartan Potassium by direct compression techniques. Int J Res Pharm Sci 2010; 1(3):290-95.
10. Pandya S And Shah S. Optimization of Effect of Superdisintegrants and Subliming Agent on Orodispersible Tablet of Ondansetron Resinate. Int J Pharm Sci Res 2010;1(7):123-31.
11. Roy D, Bhowmik D, Kumar KS. A comprehensive review on superdisintegrants used in orodispersible tablets. Indian Journal of Research in Pharmacy and Biotechnology. 2014;2(4):1297-303.
12. Abbas A, Ibrahim W, Sakran W, Badawi A. Evaluation and Characterization of Sildenafil 50 mg Orodispersible Tablets Using Sublimation Technique. Journal of Advanced Pharmacy Research. 2018 Oct 1;2(4):292-311. https://doi.org/10.21608/aprh.2018.5126.1065
13. Kumar R, Patil S, Patil MB, Patil SR, Paschapur MS. Formulation evaluation of mouth dissolving tablets of fenofibrate using sublimation technique. Int J Chem Tech Res. 2009;1(4):840-50.
14. Reza HM, Islam T, Shohel M, Jain P. Formulation Design and Evaluation of Baclofen Mouth Dissolving Tablets. European Journal of applied sciences. 2012;4(3):110-6.
15. Ramakant S, Thiruvengadarajan V, Gopinath C. Formulation and Development of Orodispersible Tablet of Baclofen by Effervescent Method. Journal of Basic and Applied Research in Biomedicine. 2016;2(3):291-4.
16. Katzung BG Basic Clinical Pharmacology; McGraw hill companies USA 2001; 9:1475-80.
17. Ruba Fahmi Abbas development of spectrophotometric method for the estimation of baclofen drug, International Research Journal of Pharmacy, 2018, 9 (11), 9. https://doi.org/10.7897/2230-8407.0911254
18. Panghal A, Sachdeva M, Agarwal V. Formulation & Development of Baclofen microemulsion incorporated into Transdermal patch. Journal of Drug Delivery and Therapeutics. 2022 Sep 15;12(5):55-63. https://doi.org/10.22270/jddt.v12i5.5586
19. Keservani RK, Sharma AK, Ramteke S. Novel vesicular approaches for topical delivery of Baclofen via noisome. Lat Am J Pharm. 2010 Dec 1;29(8):1364-70.
20. Mitesh N and Yadav AV. Cinnarizine Orodispersible Tablets: A Chitosan based fast mouth dissolving technology. Int J Pharm tech Res Oct-Dec 2009; 1(4):1079-91.
21. Lachman L, Lieberman HA. The theory and practice of Industrial pharmacy, CBS publication & distributors 2009; 171-94, 293-345. 2 Aulton ME. Pharmaceutics the science of dosage form design. Churchill Livingstone; 2:397-400.
22. Indian pharmacopoeia, Government of India, Ministry of health & family welfare. The controller of publication New Delhi 1996; 2 (13.1): A145.
23. Bhardwaj S, Jain V, Jat RC, Mangal A, Jain S. Formulation and Evaluation of Fast Dissolving Tablet of Aceclofenac. Int J Drug Delivery 2010;2: 93-97. https://doi.org/10.5138/ijdd.2010.0975.0215.02017
24. Suryakanta N, Das B, Tarai DK, Panda D, Sahoo J. Formulation and evaluation of Salbutamol Sulphate fast dissolving tablet. J Pharm Res 2010; 3(4):824-827
25. Costa, P. Lobo, JMS. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences, 2001; 13, 123-133. https://doi.org/10.1016/S0928-0987(01)00095-1 PMid:11297896
Published
Abstract Display: 927 
PDF Downloads: 667 PDF Downloads: 117 How to Cite
Issue
Section
Copyright (c) 2025 K. M. Manjanna, C Mounika , G. Govind Reddy, G. Siva Krishna, Mohd Azharuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.